Live Breaking News & Updates on Pandemic Bites

Stay updated with breaking news from Pandemic bites. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Global Molecular Diagnostics for Cancer Markets Report 2021-2025: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs; COVID-19 Causes Resources Shift


7 Molecular Diagnostics Recent Developments
7.1 Recent Developments - Importance and How to Use This Section
7.1.1 Importance of These Developments
7.1.2 How to Use This Section
7.2 Nucleix to Invest in Early-Stage Lung Cancer Dx
7.3 Invitae to Acquire Genosity for $200M
7.4 Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test
7.5 Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience
7.6 Natera Revenues Grow 35 Percent
7.7 AnchorDx Closes $40M Financing Round
7.8 Exact Sciences Strategy for End-to-End Cancer Testing
7.9 Genomics England: Whole Genome Sequencing for Cancer Patients to Launch
7.10 Singlera Genomics Closes $150M Funding for Cancer Screening
7.11 Biocartis GeneproDx, Endpoint Health Collaborate on Tests for Idylla Platform ....

United States , New York , Miltenyi Biotec , Yourgene Elucigene , Qiagen Gmbh , Sysmex Inostics , Bristol Myers Squibb , Siemens Healthineers , Biocartis Geneprodx , Laura Wood , Academic Research Lab , Testing Lab , Mdx Companion Dx Development , Sciences Strategy For Cancer Testing , Technology Development , Us Medicare Expenditures For Laboratory Testing , Singlera Genomics Inc , Physician Lab , Mdx Clinical Laboratory , Servier Sign Liquid Biopsy Services Deal , Enzo Life Sciences Inc , Office Hours Call , Biodesix Inc , Datar Cancer Genetics , Fluidigm Corp , Accuragen Inc ,

Global Cancer Molecular Diagnostics Markets 2021-2025 - New Diagnostics Create New Markets


A market with fundamental growth factors is impacted by the COVID-19 Pandemic.
Molecular Diagnostics for Cancer is positioned to directly benefit from the explosion in genomics knowledge but shifting resources to deal with the COVID emergency may interrupt growth. Learn all about it in this new report. the publisher includes a special segment, Cancer Companion Diagnostics, a new segment of the market that is reshaping the industry. And now over 130 companies are profiled. A range of dynamic trends are pushing market growth and company valuations.
Working against this dynamic market are the forces of the COVID Driven Recession. The publisher s latest numbers factor in the different COVID forces, their timing, and their effect on growth. ....

New York , United States , Miltenyi Biotec , Yourgene Elucigene , Qiagen Gmbh , Sysmex Inostics , Bristol Myers Squibb , Siemens Healthineers , Laura Wood , Academic Research Lab , Testing Lab , Mdx Companion Dx Development , Public National , Technology Development , Us Medicare Expenditures For Laboratory Testing , Physician Lab , Physician Office Lab , Servier Sign Liquid Biopsy Services Deal , Enzo Life Sciences Inc , Office Hours Call , Biodesix Inc , Datar Cancer Genetics , Fluidigm Corp , Accuragen Inc , Business Development Staff , Genefirst Ltd ,